期刊文献+

婴幼儿先天性心脏病术前氨基末端B型脑利钠肽前体检测的临床意义 被引量:5

Clinical importance of preoperative measurement of plasma amino-terminal pro-B-type natriuretic peptide in infants with congenital heart disease
原文传递
导出
摘要 目的检测婴幼儿先天性心脏病(CHD)术前血浆氨基末端B型脑利钠肽前体(NT-proBNP),探寻CHD患儿术前合并充血性心力衰竭(CHF)血浆NT-proBNP诊断界值,对术前心功能维护的效果进行评价。方法测定2010年6月至2013年6月收治的120例术前婴幼儿CHD患儿及100例正常儿童(对照组)血浆NT-proBNP水平,将合并CHF的CHD患儿(CHF组)又分为婴儿组(<1岁)和幼儿组(≥1岁),探寻NTproBNP在不同年龄段CHF患儿中诊断CHF的界值。结果 120例婴幼儿CHD中41例符合改良Ross心力衰竭诊断标准,CHF组NT-proBNP诊断CHF界值为≥498 ng/L,婴儿组和幼儿组的NT-proBNP诊断CHF界值分别为557 ng/L、452 ng/L。41例CHF患儿经治疗后NT-proBNP较治疗前明显下降,其差异有统计学意义(P<0.001)。结论婴儿组与幼儿组的NT-proBNP诊断CHF的界值存在明显差异。血浆NT-proBNP可作为CHD婴幼儿术前心功能评估的一个指标。 Objective To define cut-off values of plasma amino-terminal pro-B-type natriuretic peptide (NT- ProBNP) for the diagnosis of congenital heart failure (CHF) and evaluate the importance of plasma NT-ProBNP measurement in the assessment of cardiac function prior to heart surgery in infants with congenital heart disease (CHD). Methods Plasma levels of NT-proBNP were measured in 120 infants with CHD before heart surgery and in 100 age-matched healthy infants between June 2010 and June 2013. The data were stratified based on the presence or absence of CHF in the whole group of CHD infants and on age (i.e., 〈1 year and 〉l year) and time (i.e., before surgery) within the subgroup of CHF infants. Results Of the 120 infants with CHD, 41 met the criteria for CHF defined in the Ross Classification for Heart Failure in Infants.The cut-off values of plasma NT-ProBNP were _〉498 ng/L for infants of all ages, 557 ng/L for 〈1 year age group and 452 ng/L for _〉1 year age group, respectively, in the 41 CHF patients. In CHF infants, plasma NT-proBNP was significantly decreased after protecting of cardiac function (P〈0.001). Conclusions The cut-off values of plasma NT-ProBNP for CHF differ between infants 〈1 year and infants 〉1 year. Moreover, plasma NT-ProBNP can be used as an additional parameter in the preoperative assessment of cardiac function in CHD infants.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2014年第1期40-43,共4页 Chinese Journal of Contemporary Pediatrics
基金 2011年广东省第一批科学事业费计划项目(编号:2011B031800134) 2010年佛山市医学类科技攻关项目(编号:201008189)
关键词 先天性心脏病 充血性心力衰竭 氨基末端B型脑利钠肽前体 儿童 Congenital heart disease Congestive heart failure Amino-terminal pro-B-type natriuretic peptide Child
  • 相关文献

参考文献9

  • 1沈晓明,王卫平.儿科学[M].第7版,北京:人民卫生出版社,2010.136. 被引量:62
  • 2Laer S, Mir TS, Behn F, et al. Carvedilol therapy in pediatric patients with congestive heart failure:a study investigating clinical and pharmacokinetic parameters[J]. Am Heart J, 2002, 143(5): 916-922. 被引量:1
  • 3Sugimoto M, Manabe H, Nakau K, et al. The role of N-terminal pro-B- type natriuretic peptide in the diagnosis of congestive heart failure in children[J]. Circ J, 2010, 74(5): 998-1005. 被引量:1
  • 4de Filippi CR, de Lemos JA, Tkaczuk AT, et al. Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults[J]. J Am Coil Cardiol, 2012, 60(24): 2539-2547. 被引量:1
  • 5Rusconi PG, Ludwig DA, Ratnasamy C, et al. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure[J]. Am Heart J, 2010, 160(4): 776-783. 被引量:1
  • 6Connolly D, Rutkowski M, Auslender M, et al. The New York university pediatric heart failure index: a new method of quantifying chronic heart failure severity in children[J]. J Pediatr, 2001, 138(5): 644-648. 被引量:1
  • 7Saunders M, Gorelick MH. Nelson textbook of pediatrics[M]. 19th ed. Philadelphia: Saunders Elsevier, 2011: 280. 被引量:1
  • 8邓明红,林春旺,江少虎,吴彤,汪江萍,张金凤,欧阳辉,曾祥林.氨基末端B型利钠肽前体和改良Ross标准对急性心力衰竭诊断界值的探讨[J].广东医学,2013,34(11):1698-1700. 被引量:19
  • 9Reithmann C, Reber D, Kozlik-Feldmann R, et al. A post receptor defect of adenylyl cyclase in severely failing myocardium from chidren with congenital heart disease[J]. Eur J Pharmacol, 1997, 330: 79-86. 被引量:1

二级参考文献8

  • 1ROSS R D, BOLLINGER R 0,PINSKY W W. Grading the seve-rity of congestive heart failure in infants [ J]. J Pediatr Cardiol,1992, 13(2) : 72 -75. 被引量:1
  • 2LAER S, MIR T S, BEHN F,et al. Carvedilol therapy in pediat-ric patients with congestive heart failure : a study investigating clini-cal and pharmacokinetic parameters[ J]. Am Heart J, 2002, 143(5): 916-922. 被引量:1
  • 3CONNOLLY D, RUTKOWSKI M, AUSLENDER M,et al. TheNew York University Pediatric Heart Failure Index : a new methodof quantifying chronic heart failure severity in childrenf J]. J Pedi-atr, 2001, 138(5): 644 -648. 被引量:1
  • 4HAAPIO M,HOUSE A A,DE CAL M, et al. Heart - kidney bio-markers in patients undergoing cardiac stress testing [ J ]. Int JNephrol, 2010,2011: 425923. 被引量:1
  • 5SUGIMOTO M, MANABE H,NAKAU K, et al. The role of N-terminal pro - B - type natriuretic peptide in the diagnosis of con-gestive heart failure in children. Correlation with the heart failurescore and comparison with B - type natriuretic peptide [J]. Circ J,2010,74(5): 998 -1005. 被引量:1
  • 6HUSCONI P,LUDWIG D A, RATNASAMY C,et al. Serialmeasurements of serum NT - proBNP as markers of left ventricularsystolic function and remodeling in children with heart failure[ J].Am Heart J, 2010,160(4) : 776 -783. 被引量:1
  • 7REITHMANN C, REBER D, KOZLIK FELDMANN R, et al. Apost - receptor defect of adenylyl cyclase in severely failing myo-cardium fron chidren with congenital heart disease [ J ]. Eur JPharmacol, 1997,330(1): 79 -86. 被引量:1
  • 8XUE Y,CHAN J,SAKARIYA S, et al. Biomarker - guided treat-ment of congestive heart f ailere[ J]. Congest Heart Fail,2010,16(Suppl 1) : S62-S67. 被引量:1

共引文献79

同被引文献42

  • 1Emdin M, Clerico A, Clemenza F, et al. Recommendations for the clinical use of cardiac natriuretic peptides[ Jl. hal Heart J, 2005,6 (5): 430-446. 被引量:1
  • 2Kock A, Kitzsteiner T, Zink S, et al. Impact of cardiac surgery on plasma levels of B-type natriuretic peptides in children with congeni- tal heart disease[Jl. Int J Cardiol, 2007, 114(3): 339-344. 被引量:1
  • 3Gessler P, Knirseh W, Schmitt B, et al. Prognosite value of plasma N-terminal pro-brain natriuretic pcptide in children with congenital heart defects and open-heart surgery [ J ]. J Pediatr, 2006, 148 (3) : 372 - 376. 被引量:1
  • 4Kumar M, Sharma R, Sethi SK, et al. Vasoactive inotrope score as a tool for clinical care in childrerL post cardiac surgery[ .11. Indian ] Crit Care Med, 2014, 18(10) : 653 -658. 被引量:1
  • 5Sethi SK, Goyal D, Yadav DK, et al. Predictors of acute kidney injury post-cardiopulmonary bypass in children[ Jl. Clin Exp Neph- l to1, 2011, 15(4) : 529 -534. 被引量:1
  • 6Clerlco A, Emdin M. Diagnositlc accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review [ J ]. Clin Chem, 2004, 50(1) : 33 -50. 被引量:1
  • 7Cantinotti M, Giovannini S, Murzi B, et al. Diagnositic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart disease [ J]. Clin Chem Lab Med, 2011, 49(4) : 567 -580. 被引量:1
  • 8Westerlind A, Wahlander H, Berggren H, et al. Plasma levels of natriuretic peptide type B and A in children with heart disease with different types of cardiac load or systolic dysfunction [ J ]. Clin Physiol Funct Imaging, 2008, 28 (4) : 277 - 284. 被引量:1
  • 9Kavga M, Varlamis G, Giannopoulos A, et al. Correlation of plasma B-type natriuretic peptide with shunt volume in children with congenital heart disease involving left-to-right shunt [J]. Hellenic J Cardiol, 2013, 54(3) : 192 - 198. 被引量:1
  • 10Perez-Piaya MR, Abarca E, Soler V, et al. Levels of N-terminal-pro- brain natriuretic peptide in congenital heart disease surgery and its value as a predictive biomarker [ J ]. Interact Cardiovasc Thorac Surg, 2011,12(3) : 461 -466. 被引量:1

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部